Literature DB >> 8099332

Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells.

G McAllister1, M R Knowles, S Patel, R Marwood, F Emms, G R Seabrook, M Graziano, D Borkowski, P J Hey, S B Freedman.   

Abstract

The D2 dopamine receptor is known to be functionally coupled when expressed in CHO cells, whereas the effector systems for the D3 dopamine receptor remain unclear. A chimeric, human D3/D2 receptor (hD3/D2) was constructed containing the third intracellular loop region of the D2 receptor. CHO cells stably expressing the D2, D3, or hD3/D2 receptors were created and the pharmacology of the receptors was examined. The chimeric hD3/D2 receptor retained D3-like affinities for dopaminergic ligands. However, in contrast to the D2 receptor neither the D3 receptor nor the hD3/D2 receptor could functionally couple to the adenylate cyclase or arachidonic acid release mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099332     DOI: 10.1016/0014-5793(93)81537-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.

Authors:  Tal Ilani; C Simone Fishburn; Berta Levavi-Sivan; Shari Carmon; Lily Raveh; Sara Fuchs
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

2.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

3.  Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells.

Authors:  G R Seabrook; G McAllister; M R Knowles; J Myers; H Sinclair; S Patel; S B Freedman; J A Kemp
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors.

Authors:  G R Seabrook; M Knowles; N Brown; J Myers; H Sinclair; S Patel; S B Freedman; G McAllister
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells.

Authors:  G R Seabrook; J A Kemp; S B Freedman; S Patel; H A Sinclair; G McAllister
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

6.  Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Sujung J Yoon; In Kyoon Lyoo; Hengjun J Kim; Tae-Suk Kim; Young Hoon Sung; Namkug Kim; Scott E Lukas; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

7.  The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells.

Authors:  Karim Melliti; Manfred Grabner; Guy R Seabrook
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.